
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
Leah Davis, Matthias Recktenwald, Evan Hutt, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1259-1259
Open Access | Times Cited: 50
Leah Davis, Matthias Recktenwald, Evan Hutt, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1259-1259
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 156
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 156
Tumor hypoxia: From basic knowledge to therapeutic implications
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 85
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 85
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges
Xiaoyi Yuan, Wei Ruan, Bentley J. Bobrow, et al.
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 3, pp. 175-200
Closed Access | Times Cited: 64
Xiaoyi Yuan, Wei Ruan, Bentley J. Bobrow, et al.
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 3, pp. 175-200
Closed Access | Times Cited: 64
HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects
Yi Shi, Daniele M. Gilkes
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 3
Yi Shi, Daniele M. Gilkes
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access | Times Cited: 3
Targeting intratumoral hypoxia to enhance anti-tumor immunity
Gregg L. Semenza
Seminars in Cancer Biology (2023) Vol. 96, pp. 5-10
Open Access | Times Cited: 22
Gregg L. Semenza
Seminars in Cancer Biology (2023) Vol. 96, pp. 5-10
Open Access | Times Cited: 22
Regulation of the HIF switch in human endothelial and cancer cells
Jakub Sławski, Maciej Jaśkiewicz, Anna Barton, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151386-151386
Open Access | Times Cited: 9
Jakub Sławski, Maciej Jaśkiewicz, Anna Barton, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151386-151386
Open Access | Times Cited: 9
Exosomes‐mediated crosstalk between glioma and immune cells in the tumor microenvironment
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 16
Xu Guo, Rui Sui, Haozhe Piao
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2074-2085
Open Access | Times Cited: 16
HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)
Chang W. Song, Hyunkyung Kim, Haeun Cho, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3273-3273
Open Access | Times Cited: 26
Chang W. Song, Hyunkyung Kim, Haeun Cho, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3273-3273
Open Access | Times Cited: 26
HIF1A, EPAS1, and VEGFA: angiogenesis and hypoxia-related gene expression in endometrium and endometrial epithelial tumors
Monika Englert-Golon, Małgorzata Tokłowicz, Aleksandra Żbikowska, et al.
Journal of Applied Genetics (2025)
Open Access
Monika Englert-Golon, Małgorzata Tokłowicz, Aleksandra Żbikowska, et al.
Journal of Applied Genetics (2025)
Open Access
Association between single nucleotide polymorphisms in EPAS1 and PPARA genes and high altitude polycythemia in Chinese Tibetan population
Ziyi Chen, Zhaomei Dong, Rong Zeng, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Ziyi Chen, Zhaomei Dong, Rong Zeng, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Oxidant-Based Cytotoxic Agents During Aging: From Disturbed Energy Metabolism to Chronic Inflammation and Disease Progression
Jürgen Arnhold
Biomolecules (2025) Vol. 15, Iss. 4, pp. 547-547
Open Access
Jürgen Arnhold
Biomolecules (2025) Vol. 15, Iss. 4, pp. 547-547
Open Access
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications
Wenjie Chen, Yingjie Wang
Oncogene (2025)
Closed Access
Wenjie Chen, Yingjie Wang
Oncogene (2025)
Closed Access
Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1
Yanymee N. Guillen Quispe, Su‐Jung Kim, Soma Saeidi, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 296-307
Closed Access | Times Cited: 9
Yanymee N. Guillen Quispe, Su‐Jung Kim, Soma Saeidi, et al.
Free Radical Biology and Medicine (2023) Vol. 207, pp. 296-307
Closed Access | Times Cited: 9
Engineering transcriptional regulation for cell-based therapies
Matthias Recktenwald, Evan Hutt, Leah Davis, et al.
SLAS TECHNOLOGY (2024) Vol. 29, Iss. 2, pp. 100121-100121
Open Access | Times Cited: 3
Matthias Recktenwald, Evan Hutt, Leah Davis, et al.
SLAS TECHNOLOGY (2024) Vol. 29, Iss. 2, pp. 100121-100121
Open Access | Times Cited: 3
HIF-1 mediated metabolic reprogramming in cancer: Mechanisms and therapeutic implications
Nikita Taneja, Akansha Chauhan, Ritu Kulshreshtha, et al.
Life Sciences (2024) Vol. 352, pp. 122890-122890
Closed Access | Times Cited: 3
Nikita Taneja, Akansha Chauhan, Ritu Kulshreshtha, et al.
Life Sciences (2024) Vol. 352, pp. 122890-122890
Closed Access | Times Cited: 3
Progress in the discovery and development of anticancer agents from marine cyanobacteria
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 3
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 3
Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
RF. Zaarour, Marcelo Lima Ribeiro, Bruno Azzarone, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
RF. Zaarour, Marcelo Lima Ribeiro, Bruno Azzarone, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Boosting Clear Cell Renal Carcinoma-Specific Drug Discovery Using a Deep Learning Algorithm and Single-Cell Analysis
Yishu Wang, Xiaohong Chen, Ningjun Tang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4134-4134
Open Access | Times Cited: 2
Yishu Wang, Xiaohong Chen, Ningjun Tang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4134-4134
Open Access | Times Cited: 2
Pharmacological induction of the hypoxia response pathway in Huh7 hepatoma cells limits proliferation but increases resilience under metabolic stress
Clémence Jacquemin, Walid El Orch, Olivier Diaz, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Clémence Jacquemin, Walid El Orch, Olivier Diaz, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 2
Advancement of Nanoengineered Flavonoids for Chronic Metabolic Diseases
Himanshu Sharma, Amit Anand, Praveen Halagali, et al.
(2024), pp. 459-510
Closed Access | Times Cited: 2
Himanshu Sharma, Amit Anand, Praveen Halagali, et al.
(2024), pp. 459-510
Closed Access | Times Cited: 2
Targeting the SMURF2-HIF1α axis: a new frontier in cancer therapy
Emile M. Youssef, Shuai Zhao, Connor Purcell, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Emile M. Youssef, Shuai Zhao, Connor Purcell, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling
Vincenzo Formica, Silvia Riondino, Cristina Morelli, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 222-236
Closed Access | Times Cited: 5
Vincenzo Formica, Silvia Riondino, Cristina Morelli, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 222-236
Closed Access | Times Cited: 5
Nrf2 and Parkin-Hsc70 regulate the expression and protein stability of p62/SQSTM1 under hypoxia
Ferbian Milas Siswanto, Yumi Mitsuoka, Misato Nakamura, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Ferbian Milas Siswanto, Yumi Mitsuoka, Misato Nakamura, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Cancer Stem Cells Niche Regulation Within the Tumor Microenvironment
Zainab Siddiqui, Zaffar Equbal, Naoshad Muhammad, et al.
Current Tissue Microenvironment Reports (2024)
Closed Access | Times Cited: 1
Zainab Siddiqui, Zaffar Equbal, Naoshad Muhammad, et al.
Current Tissue Microenvironment Reports (2024)
Closed Access | Times Cited: 1
Clinical Implications of Germline Pathogenic Variants in the VHL Gene
Eitan Friedman
Springer eBooks (2024), pp. 1-26
Closed Access | Times Cited: 1
Eitan Friedman
Springer eBooks (2024), pp. 1-26
Closed Access | Times Cited: 1